Medical Condition News

RSS

$31 million PCORI funding for AAFP and Penn State to study the effectiveness of asthma treatments

The American Academy of Family Physicians, in partnership with Penn State College of Medicine, has been approved for a $31 million funding award by the Patient-Centered Outcomes Research Institute to study the comparative effectiveness of asthma treatments.

26 Jul 2022

Genetic tests do little to accurately identify cardiovascular risks compared to simple health assessment

A genetic risk for heart disease is far less predictive of problems than actual lifestyle risk factors such as high blood pressure, high cholesterol and diabetes -- even among younger adults.

26 Jul 2022

New 'decoy receptor' molecules inhibit growth of multiple myeloma and diffuse large B cell lymphoma in mice

Researchers at Stanford University have developed "decoy receptor" molecules that inhibit the growth of both multiple myeloma (MM) and diffuse large B cell lymphoma (DLBCL) in mice.

26 Jul 2022

Cocoa reduces blood pressure and arterial stiffness, study finds

Cocoa only reduces blood pressure and arterial stiffness when elevated, a new study from the University of Surrey finds.

26 Jul 2022

People who use high potency cannabis more likely to experience addiction, psychotic disorder

As the strength or potency of cannabis products has increased internationally over the years, so have rates of people being treated for cannabis addiction, say the authors of a new study.

26 Jul 2022

SLU and industry partners report the first effective drug to treat rare, genetic liver disease

Researchers at Saint Louis University's School of Medicine, in collaboration with Arrowhead Pharmaceuticals and Takeda Pharmaceuticals, report the first effective drug to treat a rare, genetic liver disease that formerly could only be treated with a liver transplant.

26 Jul 2022

Medication optimization needed in the primary care setting for managing COPD patients

Researchers conducted a study to describe the demographic and clinical characteristics of patients receiving care for chronic obstructive pulmonary disease in the U.S. primary care setting.

26 Jul 2022

Researchers describe negative impact of COVID-19 pandemic on the treatment of TBIs

Researchers affiliated with the Council of State Neurosurgical Societies investigated the impact of the COVID-19 pandemic on the treatment of traumatic brain injuries (TBIs) by evaluating data from the Michigan Trauma Quality Improvement Program (MTQIP).

26 Jul 2022

New AI technology may aid in the discovery of therapeutic agents for neurodegenerative disorders

A research group from Nagoya University in Japan has developed an artificial intelligence for analyzing cell images that uses machine learning to predict the therapeutic effect of drugs.

25 Jul 2022

Quarantine guidance for Omicron infection

The CDC provides updated guidelines on how the U.S. population can protect themselves and others from the SARS-CoV-2 Omicron variant.

25 Jul 2022

Long-COVID is relatively infrequent, but still poses a threat

A new study suggests that long COVID complaints may not be common among COVID-19 patients as compared to the general population.

25 Jul 2022

How COVID-19 affects the brain microvasculature

A recent study discusses the effects of COVID-19 on the brain microvascular system.

25 Jul 2022

COVID-19 related acute muscle loss linked to worse outcomes

Researchers investigate acute sarcopenia prevalence in COVID-19 patients and the outcomes of this complication.

25 Jul 2022

Researchers investigate a drug used for neuromuscular weakness as potential treatment for botulism

Wake Forest Institute for Regenerative Medicine (WFIRM) researchers are investigating a drug used to treat neuromuscular weakness as a potential treatment for botulism, a rare but serious disease.

25 Jul 2022

Decreased hippocampal activity linked to worse PTSD symptoms

After a traumatic event, people with decreased activity in the hippocampus experience worse PTSD symptoms, according to new research published in JNeurosci.

25 Jul 2022

Black patients have higher risk of advanced vision loss after glaucoma diagnosis compared to whites

Black patients have a dramatically higher risk of advanced vision loss after a new diagnosis of primary open angle glaucoma (POAG) when compared to white patients, according to a new study from New York Eye and Ear Infirmary of Mount Sinai (NYEE).

25 Jul 2022

Dental health care workers report anxiety and depression symptoms during peaks of the pandemic

The first known U.S. study to evaluate the mental health of frontline dentists and dental hygienists during the pandemic found that dental health care workers report anxiety and depression symptoms during peaks of transmission among the public.

25 Jul 2022

IU researchers evaluate the efficacy of a failed clinical trial drug for Alzheimer's using rigorous pipeline

Most drugs developed to treat Alzheimer's disease have for years been ineffective in clinical trials. Researchers from Indiana University School of Medicine recently evaluated the efficacy of a failed clinical trial drug using their rigorous pipeline.

25 Jul 2022

SARS-CoV-2 spike protein can lead to heart muscle injury through the inflammatory process

Heart damage is common among patients hospitalized with COVID-19, leading many to wonder how the virus affects the heart.

25 Jul 2022

Study suggests a possible treatment approach for cancer and cardiovascular disease

A key molecule for cancer metastasis has been identified as a molecule already known for its involvement in cardiovascular disease, suggesting a possible treatment approach for both diseases simultaneously.

25 Jul 2022

Medical Condition News

$31 million PCORI funding for AAFP and Penn State to study the effectiveness of asthma treatments

Genetic tests do little to accurately identify cardiovascular risks compared to simple health assessment

New 'decoy receptor' molecules inhibit growth of multiple myeloma and diffuse large B cell lymphoma in mice

Cocoa reduces blood pressure and arterial stiffness, study finds

People who use high potency cannabis more likely to experience addiction, psychotic disorder

SLU and industry partners report the first effective drug to treat rare, genetic liver disease

Medication optimization needed in the primary care setting for managing COPD patients

Researchers describe negative impact of COVID-19 pandemic on the treatment of TBIs

New AI technology may aid in the discovery of therapeutic agents for neurodegenerative disorders

Quarantine guidance for Omicron infection

Long-COVID is relatively infrequent, but still poses a threat

How COVID-19 affects the brain microvasculature

COVID-19 related acute muscle loss linked to worse outcomes

Researchers investigate a drug used for neuromuscular weakness as potential treatment for botulism

Decreased hippocampal activity linked to worse PTSD symptoms

Black patients have higher risk of advanced vision loss after glaucoma diagnosis compared to whites

Dental health care workers report anxiety and depression symptoms during peaks of the pandemic

IU researchers evaluate the efficacy of a failed clinical trial drug for Alzheimer's using rigorous pipeline

SARS-CoV-2 spike protein can lead to heart muscle injury through the inflammatory process

Study suggests a possible treatment approach for cancer and cardiovascular disease

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News